top of page
.png)
OUR STORY
Apricell Biotechnology Inc. is dedicated to reducing the attrition rate of new cancer drugs in clinical trials. In collaboration with the University, Apricell has developed a novel Organoid-on-a-Plate technology that opens up multiple opportunities for researchers and oncologists all the way from basic research and drug testing to advanced patient management
MEET THE TEAM
_edited.png)
Dr. Amir Seyfoori, PhD Founder and CEO

Amir Reza Aref, PhD
Chief Technology Officer

Elham Zabihi, PhD
Marketing Strategy Lead

Gurneil Brar
Desig and Model Development

Dr. Mohsen Akbari, PhD
Scientific Advisor, Engineering

Samuel Mercer, PhD
Business Advisor
OUR SUPPORTERS








bottom of page